ANTITUMOR ACTIVITY OF PEMBROLIZUMAB PLUS DINACICLIB IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: THE PHASE 1B KEYNOTE‐155 STUDY

G Gregory, P Walker, D Mahadevan, D Wang, J Chang, F Hernandez‐Ilizaliturri, A Klein, W Rybka, N Wagner‐Johnston, C Escobar, JM Pagel, A Mohrbacher, S Opat, J Shortt, H Ma, J Gwo, M Farooqui, H Quach